Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine.
Simona
S
Di Mario
Vittorio
V
Basevi
Silvana
S
Borsari
Sara
S
Balduzzi
Nicola
N
Magrini
D000230:Adenocarcinoma / Q000517:prevention & control*; D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000536:Aluminum Hydroxide / Q000008:administration & dosage*; D005260:Female; D052162:Human papillomavirus 16 / Q000276:immunology*; D052161:Human papillomavirus 18 / Q000276:immunology*; D006801:Humans; D008050:Lipid A / Q000031:analogs & derivatives*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D002578:Uterine Cervical Dysplasia / Q000517:prevention & control*
D000276:Adjuvants, Immunologic; D008050:Lipid A; D053918:Papillomavirus Vaccines; D000536:Aluminum Hydroxide